These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24842880)

  • 21. Preparation and testing of vaccines prepared from the envelopes of Venezuelan, eastern, and western equine encephalomyelitis viruses.
    Pedersen CE
    J Clin Microbiol; 1976 Feb; 3(2):113-8. PubMed ID: 942635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine Advances against Venezuelan, Eastern, and Western Equine Encephalitis Viruses.
    Stromberg ZR; Fischer W; Bradfute SB; Kubicek-Sutherland JZ; Hraber P
    Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32503232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A field study of persistence of antibodies in California horses vaccinated against western, eastern, and Venezuelan equine encephalomyelitis.
    Vanderwagen LC; Pearson JL; Franti CE; Tamm EL; Riemann HP; Behymer DE
    Am J Vet Res; 1975 Nov; 36(11):1567-71. PubMed ID: 1190598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposome-antigen-nucleic acid complexes protect mice from lethal challenge with western and eastern equine encephalitis viruses.
    Phillips AT; Schountz T; Toth AM; Rico AB; Jarvis DL; Powers AM; Olson KE
    J Virol; 2014 Feb; 88(3):1771-80. PubMed ID: 24257615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A humanised murine monoclonal antibody protects mice from Venezuelan equine encephalitis virus, Everglades virus and Mucambo virus when administered up to 48 h after airborne challenge.
    O'Brien LM; Goodchild SA; Phillpotts RJ; Perkins SD
    Virology; 2012 May; 426(2):100-5. PubMed ID: 22341308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. REVIEW PAPER: pathology of animal models of alphavirus encephalitis.
    Steele KE; Twenhafel NA
    Vet Pathol; 2010 Sep; 47(5):790-805. PubMed ID: 20551475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of plaque assay methods for alphaviruses.
    Juarez D; Long KC; Aguilar P; Kochel TJ; Halsey ES
    J Virol Methods; 2013 Jan; 187(1):185-9. PubMed ID: 23085307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encephalomyelitis vaccines: a Vero-derived cell culture alternative to primary duck embryonic cell cultures.
    Katz JB; Hanson SK
    Vaccine; 1988 Feb; 6(1):6. PubMed ID: 2833043
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of the nucleotide sequences of eastern and western equine encephalomyelitis viruses with those of other alphaviruses and related RNA viruses.
    Weaver SC; Hagenbaugh A; Bellew LA; Netesov SV; Volchkov VE; Chang GJ; Clarke DK; Gousset L; Scott TW; Trent DW
    Virology; 1993 Nov; 197(1):375-90. PubMed ID: 8105605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant chimeric western and eastern equine encephalitis viruses as potential vaccine candidates.
    Schoepp RJ; Smith JF; Parker MD
    Virology; 2002 Oct; 302(2):299-309. PubMed ID: 12441074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolutionary genetics and vector adaptation of recombinant viruses of the western equine encephalitis antigenic complex provides new insights into alphavirus diversity and host switching.
    Allison AB; Stallknecht DE; Holmes EC
    Virology; 2015 Jan; 474():154-62. PubMed ID: 25463613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can understanding the virulence mechanisms of RNA viruses lead us to a vaccine against eastern equine encephalitis virus and other alphaviruses?
    Trobaugh DW; Ryman KD; Klimstra WB
    Expert Rev Vaccines; 2014 Dec; 13(12):1423-5. PubMed ID: 25073901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation in humans of a new, inactivated vaccine for Venezuelan equine encephalitis virus (C-84).
    Edelman R; Ascher MS; Oster CN; Ramsburg HH; Cole FE; Eddy GA
    J Infect Dis; 1979 Nov; 140(5):708-15. PubMed ID: 528788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic diversity of Venezuelan alphaviruses and circulation of a Venezuelan equine encephalitis virus subtype IAB strain during an interepizootic period.
    Medina G; Garzaro DJ; Barrios M; Auguste AJ; Weaver SC; Pujol FH
    Am J Trop Med Hyg; 2015 Jul; 93(1):7-10. PubMed ID: 25940191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inactivation of Venezuelan Equine Encephalitis Virus Genome Using Two Methods.
    Behnia M; Baer A; Skidmore AM; Lehman CW; Bracci N; Kehn-Hall K; Bradfute SB
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Specificity of the murine T helper cell immune response to various alphaviruses.
    Mathews JH; Roehrig JT
    J Gen Virol; 1989 Nov; 70 ( Pt 11)():2877-86. PubMed ID: 2479713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the hemagglutination activity domains of the Venezuelan equine encephalomyelitis and eastern equine encephalomyelitis viruses.
    Razumov IA; Khusainova AD; Agapov EV; Gaidamovich SYa ; Pereboev AV; Kolykhalov AA; Netesov SV; Loktev VB
    Intervirology; 1994; 37(6):356-60. PubMed ID: 8586535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic interference from sequential administration of live attenuated alphavirus vaccines.
    McClain DJ; Pittman PR; Ramsburg HH; Nelson GO; Rossi CA; Mangiafico JA; Schmaljohn AL; Malinoski FJ
    J Infect Dis; 1998 Mar; 177(3):634-41. PubMed ID: 9498442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alphavirus-based vaccines.
    Lundstrom K
    Viruses; 2014 Jun; 6(6):2392-415. PubMed ID: 24937089
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody studies in ponies vaccinated with Venezuelan equine encephalomyelitis (strain TC-83) and other alphavirus vaccines.
    Ferguson JA; Reeves WC; Hardy JL
    Am J Vet Res; 1977 Apr; 38(4):425-30. PubMed ID: 851275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.